You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

PENTOXIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Pentoxil patents expire, and what generic alternatives are available?

Pentoxil is a drug marketed by Upsher Smith Labs and is included in one NDA.

The generic ingredient in PENTOXIL is pentoxifylline. There are fourteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the pentoxifylline profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Pentoxil

A generic version of PENTOXIL was approved as pentoxifylline by RISING on July 8th, 1997.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PENTOXIL?
  • What are the global sales for PENTOXIL?
  • What is Average Wholesale Price for PENTOXIL?
Summary for PENTOXIL
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 81
Clinical Trials: 2
DailyMed Link:PENTOXIL at DailyMed
Drug patent expirations by year for PENTOXIL
Recent Clinical Trials for PENTOXIL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 3
Mayo ClinicPhase 3
National Institute of Mental Health (NIMH)Phase 2

See all PENTOXIL clinical trials

US Patents and Regulatory Information for PENTOXIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Upsher Smith Labs PENTOXIL pentoxifylline TABLET, EXTENDED RELEASE;ORAL 074962-001 Mar 31, 1999 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.